Home / Chroniques / Vaccine passport: why so much doubt?
vaccine passport
π Health and biotech π Society

Vaccine passport: why so much doubt?

Etienne Minvielle
Etienne Minvielle
Director of the Centre de Recherche en Gestion at Ecole Polytechnique (IP Paris)

Accord­ing to a sur­vey by the Eco­nom­ic, Social and Envir­on­ment­al Coun­cil 1, 67% of French people are “highly unfa­vour­able” to the adop­tion of a “vac­cine pass­port”. How do you explain this opposition?

Étienne Min­vi­elle. The pass­port offers a way to reopen places that are cur­rently closed and to start trav­el­ling again. But many people see it as a form of infringe­ment of indi­vidu­al freedoms and a poten­tial source of inequal­ity. The pass­port is sup­posed to be an incent­ive for vac­cin­a­tion, yet access to vac­cines is still prob­lem­at­ic. So, to gen­er­al­ise a vac­cine pass­port now would be giv­ing freedoms to those who lucky few who have been able to bene­fit from it so far. 

Hence, this would cre­ate inequal­it­ies on both nation­al and inter­na­tion­al levels, likely to fuel bit­ter­ness of non-vac­cin­ated indi­vidu­als and sus­pi­cions of enti­tle­ment. The crisis is put­ting social cohe­sion to the test, and the reluct­ance to put this pass­port into cir­cu­la­tion is a testi­mony to this.

Who are those who oppose this passport?

There is wide­spread fear of sur­veil­lance among most French people and the pass­port, since it increases trace­ab­il­ity, increases this fear. Many people also have doubts about the risks and effect­ive­ness of vac­cines. We can see this clearly with the con­tro­versy sur­round­ing AstraZeneca’s doses: people are wor­ried about the lack of hind­sight and fear poten­tial side effects.

But it’s not just the clin­ic­al sphere that is con­cerned. Many people under­stand the med­ic­al benefit/risk ratio but are still scep­tic­al about the inten­tions of those who are push­ing for vac­cin­a­tion. There is a social – almost iden­tity-based – rejec­tion of polit­ic­al and med­ic­al elite. This scep­ti­cism can bor­der on con­spir­acy when cit­izens come to ima­gine col­lu­sion between elites and phar­ma­ceut­ic­al labor­at­or­ies. We are there­fore see­ing the emer­gence of a form of res­ist­ance, based on the rejec­tion of the dis­course of the elite, of which the first and fore­most is the government.

There is wide­spread fear of sur­veil­lance among most French people and the pass­port, since it increases trace­ab­il­ity, increases this fear.

How can those people be con­vinced of the effect­ive­ness of vaccines?

For people who have doubts about the clin­ic­al effect­ive­ness of vac­cines, med­ic­al staff simply need to explain the clin­ic­al res­ults, which prove that vac­cines are not dan­ger­ous. In the case of AstraZeneca, for example, no link between the vac­cine and throm­bos­is has been demonstrated.

For those whose doubts are based on socio-iden­tity cri­ter­ia, the mis­take is to believe that words by doc­tors and author­ity fig­ures are enough 2. The vac­cin­a­tion of elites can even send a neg­at­ive sig­nal: the fact that Jean Cas­tex was vac­cin­ated with a dose of AstraZeneca can be inter­preted as proof of his links with the labor­at­or­ies. The response is there­fore not be clin­ic­al, rather it is social. 

We need to devel­op a dif­fer­ent kind of com­mu­nic­a­tion, based on influ­en­cers play­ing the role of “trus­ted third parties” [Pres­id­ent Mac­ron prom­ised fam­ous you­tubers McFly and Carlito to take part in one of their videos if they made a music video on pre­vent­ive meas­ures that reached 10 mil­lion views]. The vac­cin­a­tion of rap­per Booba (sug­ges­ted in a post on his Ins­tagram account) is in this sense not entirely anec­dot­al, not least because he is fol­lowed and listened to by a some of these con­spir­acy the­or­ists. The mixed reac­tion of his fans on social net­works shows the lim­its of this meth­od: people are not fooled, and often per­ceive this com­mu­nic­a­tion as an attempt at manipulation.

So, there is no mir­acle solu­tion for con­vin­cing people who doubt?

It is extremely dif­fi­cult to con­vince people who do not want to be con­vinced. To take just one example, one study showed that par­ents who were reluct­ant to vac­cin­ate their chil­dren became even more scep­tic­al when they were presen­ted with data that shattered the myth of aut­ism risk due to vac­cines 3. Although coun­ter­in­tu­it­ive, this pos­i­tion does not reflect a lack of intel­li­gence. It demon­strates that sci­entif­ic evid­ence is rejec­ted when it dis­turbs beliefs.  It is there­fore not the con­clu­sion that counts, but who pro­duces it.

The trans­mis­sion of inform­a­tion is not just a sender/receiver rela­tion­ship! It requires tak­ing into account the whole social con­text: people are not just clin­ic­al cases. In can­cer patients, for example, the rate of non-adher­ence to pre­scrip­tions is close to 20% in dif­fer­ent clin­ic­al con­di­tions 4 5. This res­ults in con­sid­er­able loss of oppor­tun­ity and is inex­plic­able from a strictly clin­ic­al point of view. In the work we are cur­rently doing, this non-adher­ence seems to be explained by social phe­nom­ena: the rela­tion­ship to life, the level of isol­a­tion, las­sit­ude or the deteri­or­a­tion of the pro­fes­sion­al situ­ation. This social dimen­sion must be taken into account to optim­ise care. The same approach must be adop­ted to under­stand the reluct­ance of cit­izens to be vac­cin­ated and the health passport.

Interview by Juliette Parmentier and Clément Boulle
1In French : https://​par​ti​cipez​.lecese​.fr/​p​a​g​e​s​/​r​e​s​u​l​t​a​t​s​-​d​e​-​l​a​-​c​o​n​s​u​l​t​a​t​i​o​n​-​s​u​r​-​l​e​-​p​a​s​s​e​p​o​r​t​-​v​a​c​cinal
2Rosen­baum, L. (2017). Res­ist­ing the sup­pres­sion of sci­ence. New Eng­land Journ­al of Medi­cine, 376(17), 1607–1609.
3Nyhan B, Reifler J, Richey S, Freed GL. Effect­ive mes­sages in vac­cine pro­mo­tion: a ran­dom­ized tri­al. Pedi­at­rics 2014; 133(4): e835-e842.
4 http://​www​.blood​journ​al​.org/​c​o​n​t​e​n​t​/​1​1​3​/​2​2​/​5​4​0​1​.​a​b​s​tract
5Pis­tilli, B., Paci, A., Fer­reira, A., Di Meglio, A., Poin­signon, V., Bardet, A., … & Vaz-Luis, I. (2020). Ser­um detec­tion of non­ad­her­ence to adjuvant tamox­ifen and breast can­cer recur­rence risk. Journ­al of Clin­ic­al Onco­logy, 38(24), 2762–2772

Contributors

Etienne Minvielle

Etienne Minvielle

Director of the Centre de Recherche en Gestion at Ecole Polytechnique (IP Paris)

A former intern at the Paris hospitals, a graduate of ESSEC and holder of a doctorate from the Ecole Polytechnique, Etienne Minvielle is also Director of Quality, Risk Management and Patient Relations at the Gustave Roussy Institute. He is director of the Centre de Recherche en Gestion (i3-CRG*) at Ecole Polytechnique (IP Paris). 
*I³-CRG: a joint research unit of CNRS, École Polytechnique - Institut Polytechnique de Paris, Télécom Paris, Mines ParisTech

Support accurate information rooted in the scientific method.

Donate